| Line Item | 2025-08-30 | Y/Y |
|---|---|---|
| Revenue | $1.45B | +9.0% |
| Cost of Revenue | $925.2M | +12.9% |
| Gross Profit | $525.7M | +2.8% |
| R&D Expense | $5.5M | +1.9% |
| SG&A Expense | $155.9M | +20.2% |
| Operating Income | $156.9M | -24.0% |
| Pre-tax Income | $135.9M | -27.0% |
| Income Tax | $32.3M | -30.9% |
| Net Income | $103.6M |
| Line Item | 2025-08-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.5M | -25.7% |
| Accounts Receivable | $165.0M | +9.5% |
| Inventory | $167.2M | +17.7% |
| Current Assets | $453.7M | +3.0% |
| Total Assets | $2.40B | -1.6% |
| Current Liabilities | $124.6M | +14.7% |
| Long-term Debt | $249.1M | -37.3% |
| Line Item | 2025-08-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $178.5M | -17.3% |
| Capital Expenditures | $20.5M | +257.7% |
| Investing Cash Flow | -$20.9M | +92.7% |
| Financing Cash Flow | -$191.2M | -265.0% |
| Free Cash Flow | $157.9M | -24.8% |
| -25.6% |
| EPS (Basic) | $1.03 | -25.9% |
| EPS (Diluted) | $1.02 | -26.1% |
| Total Liabilities |
| $589.2M |
| -16.9% |
| Stockholders' Equity | $1.81B | +4.6% |